Untitled Document

Final Program

Go directly to a day's program:
Thursday | Friday | Saturday

All General Sessions to be held in the Salone delle Signorie Ballroom on the Lobby Level

1st Advances Against Aspergillosis Meeting for Patients will be held just prior to the scientific meeting on February 3, 2010. This half-day meeting (http://www.aspergillus.org.uk/AAA/) is unique as it will consist of clinicans lecturing on aspergillosis topics directly important for patients and families of patients. The lectures will be directed toward those patients and presented in an easily understandable format. Please see the link for information on the final program and registration for this meeting before the larger scientific meeting.

Wednesday, February 3
5:00 - 7:00 pm	Early Registration Foyer delle Signorie Lobby Level

Thursday, February 4
7:00 - 9:00 am	Registration
8:00 - 8:45 am	Pre-program workshop: Alternative models for studying Aspergilli Peter A. Warn, PhD
9:00 - 9:15	Opening ceremony David A. Stevens, MD
Session 1: Interactions of Aspergillus With the Lung – New Insights Moderators: Jean-Paul Latge, PhD & Antonio Cassone, PhD
9:15 - 9:40	Innate immunity defenses Chad Steele, PhD
9:40 - 10:05	NADPH oxidase regulation of inflammation Brahm H. Segal, MD
10:05 - 10:30	Aspergillus and response to hypoxia Robert A. Cramer, Jr., PhD
10:30 - 10:55	Biofilms in the clinical setting Frank-Michael Mueller, MD
10:55 - 11:25	Coffee / Tea Break Piazzetta across from Salone delle Signorie Ballroom
Session 2: Antifungal Resistance Moderators: David Perlin, PhD & Nir Osherov, PhD
11:25 - 11:50	*Azole resistance in Aspergillus* – is it a problem?** Susan J. Howard, PhD
11:50 am - 12:15 pm	Susceptibility testing, breakpoints and molecular testing Maiken Cavling Arendrup, MD, PhD
12:15 - 12:40	The unfolded protein stress response and resistance David S. Askew, PhD
12:40 - 1:05	Intrinsically resistant species Paul E. Verweij, MD, PhD
1:05	Lunch Piazzetta across from Salone delle Signorie Ballroom
1:30	Workshop - Interesting clinical dilemmas John E. Bennett, MD and Dimitrios P. Kontoyiannis, MD
Session 3: Incidence and Prevalence of Aspergillosis Moderator: Maurizio Sanginetti, MD & Emilio Bouza, MD
2:30 - 2:55	Epidemiology and outcomes of aspergillosis in the 21st century: Strengths and weaknesses of surveillance databases Dionissios Neofytos, MD
2:55 - 3:20	IA in developing countries Arunaloke Chakrabarti, MD
3:20 - 3:55	ABPA in CF and asthma Marianne Skov, MD
3:55 - 4:20	Rising tide of TB and chronic pulmonary aspergillosis David W. Denning, MD
4:20 - 4:50	Coffee / Tea Break Piazzetta across from Salone delle Signorie Ballroom
Session 4: Immunization and immunology of Aspergillosis Moderators: Brahm Segal, MD & Luigina Romani, MD, PhD
4:50 - 5:15	Aspergillosis in leukaemia Morena Caira, MD
5:15 - 5:40	Aspergillosis in transplant patients Faouzi Saliba, MD
5:40 - 6:05	*Candidate Aspergillus* vaccines** David A. Stevens, MD
6:05 - 6:30	Adoptive T cell immunotherapy - into the clinic? Thomas Lehrnbecher, MD, PhD
7:00 - 9:00 pm	Welcome reception and poster session #1 Salone delle Signorie Ballroom and Foyer
Dinner	Dinner - On your own

Friday, February 5, 2010 [back to top of page]
8:00 - 8:45 am	Meet the Professor *Naming Aspergillus* species: evolving approaches to facilitate stability** David L. Hawksworth, CBE
Session 5: New and Old Diagnostic Approaches Moderators: John E. Bennett, MD & Paul E. Verweij, MD, PhD
9:00 - 9:25	Primary diagnostic approaches – molecular testing Stephane Bretagne, MD
9:25 - 9:50	Galactomannan and response to therapy Thomas F. Patterson, MD
9:50 - 10:15	Technetium scanning and aspergillosis Antonella Lupetti, MD
10:15 - 10:40	Primary diagnostic approaches – breath volatiles Stephen T. Chambers, PhD
10:40 - 11:10	Coffee / Tea Break Piazzetta across from Salone delle Signorie Ballroom
Session 6: Risk Factors for IA Moderators: Oliver Cornely, MD & Corrado Girmenia, MD
11:10 - 11:35	Clinical risk factors John W. Baddley, MD
11:35 am - 12:00 pm	TLRs as a risk factor Pierre-Yves Bochud, MD
12:00 - 12:25	Innate immune defects as risk factors Agostinto Carvalho, MD
12:25 - 12:50	Aspergillosis: Nosocomial or community acquired? Philippe Vanhems, MD
Session 7: Lunch Seminar Moderator: Katusuhiko Kamei, MD, PhD
12:50	Lunch Piazzetta across from Salone delle Signorie Ballroom Top six papers in aspergillosis in 2009/10 David Perlin, PhD & Claudio Viscoli, MD
2:00 pm	Depart for Vatican Tour and Dinner

Saturday, February 6, 2010 [back to top of page]
8:00-8:45 am	Meet the Professor *Syndromes caused by Aspergillus* species and utility of immunodiagnostics** Kieren A, Marr, MD
Session 8: Aspergillosis in the Critically Ill Moderators: William W. Hope, MD, PhD & Livio Pagano, MD
9:00 - 9:25	Clinical risk factors and diagnosis of IA in ICU Elie Azoulay, MD
9:25 - 9:50	Severe asthma and Aspergillus Ritesh Agarwal, MD
9:50 - 10:15	Monitoring immunoparesis in ICU Guillaume Monneret, MD
10:15 - 10:40	Is combination therapy always justified for IA in ICU? Raoul Herbrecht, MD Mycoses Study Group Lecturer
10:40 - 11:10	Coffee / Tea Break Piazzetta across from Salone delle Signorie Ballroom
Session 9: Aspergillus, Eosinophils and IgE – What Actually Goes On Moderators: Richard B. Moss, MD & Arunaloke Chakrabarti, MD
11:10 - 11:35	*Impact of Aspergillus* proteases on allergic sensitization and the lung** David B. Corry, MD
11:35 am - 12:00 pm	The Dectin-2/FcRgamma/Syk/cys-LT axis and allergy Yoshihide Kanaoka, PhD
12:00 - 12:25	*Monitoring Aspergillus* allergic sensitization** Adriano Mari, MD
12:30	Lunch and poster session #2 Piazzetta and Salone delle Signorie Ballroom
Session 10: Surgical Infection and Outbreaks Moderators: Cornelia Lass-Florl, PhD & Marianna Viviani, PhD
2:00 - 2:25	Aspergillus endocarditis Joseph McCormack, MB, BCh
2:25 - 2:50	Outbreaks of aspergillosis Malcolm Richardson, PhD
2:50 - 3:15	Outbreak investigation examples S. Arun Balajee, PhD
Young Investigator Presentations (Selected by the Scientific Committee) Moderator: Karl V. Clemons, PhD
3:15 - 3:25	#1
3:25 - 3:35	#2
3:35 - 3:45	#3
3:45 - 4:00	Discussion
4:00 - 4:30	Coffee / Tea Break Piazzetta across from Salone delle Signorie Ballroom
Session 11: Newer Treatment Strategies Moderators: Kieren A. Marr, MD & Claudio Viscoli, MD
4:30 - 4:55	Echinocandin or azole in non-neutropenic patients with IA Emilio Bouza, MD
4:55 - 5:20	Voriconazole or Ambisome in neutropenia Livio Pagano, MD
5:20 - 5:45	Role of azole level monitoring in management Elaine M. Billaud, MD
5:45 - 6:10	Newer combination therapies William J. Steinbach, MD
6:30 pm	Farewell drinks David W. Denning, MD Discussion about the next AAA meeting
Dinner	Dinner - On your own